Zyprexa Patent Valid: Lilly’s Phase I Olanzapine Trials Were Not “Public Use”

Lilly's conduct of Phase I clinical trials for Zyprexa prior to applying for a composition/use patent did not constitute a prior "public use" that would render the patent invalid, an Indianapolis federal judge ruled April 14